The SITC Advances in Cancer Immunotherapy™: Clinical Updates from ASCO20 Virtual Webinar, held on September 10, 2020, is available for continuing education credits.
Continuing Education Credit Information
Continuing Education Credits are available for physicians, nurses and pharmacists. To view full accreditation information, click here.
- Click the Register Now button.
- You will be prompted to log in or create a free account.
- Click the Request Credit button.
- On the Manage Your Credit screen, follow the instructions to select the Credit Reporting Organization you wish to claim credit for. (Note: For pharmacist completers, enter your NABP# (required).) Then click Continue.
- Complete the evaluation. Then click Submit.
- On the Confirm All Information screen, verify your Credit Reporting Organization and click Process Credit.
- On the Education Credit Profile Screen, scroll down to the Submitted Credit section to view your certificate.
For Pharmacists: Pharmacists have up to 30 days to complete the online evaluation and claim credit for participation so that information can be submitted to the CPE Monitor as required.
The webinar is intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates.
Webinar Learning Objectives
- Describe the latest advancements in combination and monotherapy treatments using immune checkpoint inhibitors for various cancers.
- Outline novel cell-based therapies under clinical investigation.
- Summarize current efforts for optimizing immunotherapy dosing and regimens.
- Michael Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center
- Shailender Bhatia, MD – University of Washington
- Stephan Grupp, MD, PhD – University of Pennsylvania
- Jose Lutzky, MD, FACP – University of Miami Sylvester Cancer Center
The recorded webinar video and slides will be available here within 24 hours after the webinar concludes.
(Please note that the on-demand webinars are not available for continuing education credits.)
Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Celgene Corporation, Exelixis, Inc., Genentech, Incyte Corporation and Merck & Co., Inc.